GlassScriptPhysician profile
Daniel Mani Cherian
NPI 1609301928
$9,378.10
in general payments reported to CMS, 2019-2025
10 companies · $4,194 in 2025
The $4,194 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,369 · 2022: $340 · 2023: $2,886 · 2024: $588 · 2025: $4,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,372 · Food and Beverage: $3,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,372.23 |
| Food and Beverage | $3,296.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,617.86 | 2024-2025 | Reflect, Excelsius Gps, Reflect |
| Orthofix Medical, INC. | $2,562.65 | 2023 | Northstar, Mariner Mis, Mariner |
| Titan Surgical Group, LLC | $1,218.83 | 2021-2022 | |
| Cerapedics INC. | $1,124.76 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $925.68 | 2022-2025 | Cascadia Interbody System, Everest Spinal System, Tritanium |
| Medtronic, INC. | $690.93 | 2021-2025 | Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology, Catalyft Pl Expandable Interbody System |
| Depuy Synthes Sales INC. | $161.54 | 2024-2025 | Velys, Symphony |
| Innovation Technologies INC | $35.06 | 2022 | |
| Dilon Technologies, INC. | $24.44 | 2025 | Hemoblast Bellows |
| Si-Bone, INC. | $16.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cherian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.